Communicable disease threats report, 8-14 July 2018, week 28
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 July 2018 and includes updates on carbapenemase-producing (OXA-48) Klebsiella pneumoniae, dengue, Ebola virus disease, poliomyelitis, MERS-CoV, mass gathering monitoring (FIFA Men's Football World Cup), measles, poliovirus type 2, rubella, Vibrio growth in the Baltic Sea, and West Nile virus.
ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level
This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae, 14 April 2016
This rapid risk assessment provides several options to reduce the risk of CRE, e.g. treatment options, transmission prevention and measures related to the healthcare system.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
ECDC country visit to Norway to discuss antimicrobial resistance issues
An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.
New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: Emergence and response in Europe
Struelens, M.J., Monnet, D.L., Magiorakos, A.P., O'Connor, F.S., Giesecke, J.
Antimicrobial resistance 2010: Global attention on carbapenemase-producing bacteria
Monnet, D.L., Suetens, C., Earnshaw, S., Gagliotti, C., Griskeviciene, J., Heuer, O.E., Khazeeva, E., Kleinkauf, N., Liljestedt, E., Magiorakos, A.-P., Santos, F., Struelens, M.J., Weber, J.T., Weist, K.
Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: Guidance from the European Centre for Disease Prevention and Control
Magiorakos, A.P., Burns, K., Rodríguez Baño, J., Borg, M., Daikos, G., Dumpis, U., Lucet, J.C., Moro, M.L., Tacconelli, E., Simonsen, G.S., Szilágyi, E., Voss, A., Weber, J.T.
Laboratory manual for carbapenem and colistin resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
This protocol is based partly on the laboratory manual developed for the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE)
Communicable Disease Threats Report, 3-9 June 2018, week 23
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 June 2018 and includes updates on dengue, Vibrio growth in the Baltic Sea, measles, rubella, hepatitis A, mass gathering monitoring, Carbapenem-resistant Enterobacteriaceae, Ebola virus disease, West Nile virus, polio and MERS-CoV.
- Carbapenem-resistant Enterobactericae
- Democratic Republic of the Congo
- Ebola haemorrhagic fever
- Ebola outbreak - North Kivu, Ituri, DRC
- Hepatitis A
- La Réunion
- Middle East respiratory syndrome coronavirus
- Public health threat
- West Nile virus infection